Non-Oil GDP Share: 76% ▲ -7.7pp vs 2020 | Saudi Unemployment: 3.5% ▲ -0.5pp vs 2023 | PIF AUM: $941.3B ▲ +$345B vs 2022 | Inbound FDI: $21.3B ▼ -6.4% vs 2023 | Female Participation: 33% ▲ -1.1pp vs 2023 | Credit Rating: Aa3/A+ ▲ Moody's / Fitch | GDP Growth: 2.0% ▲ +1.5pp vs 2023 | Umrah Pilgrims: 16.92M ▲ vs 11.3M target | Non-Oil GDP Share: 76% ▲ -7.7pp vs 2020 | Saudi Unemployment: 3.5% ▲ -0.5pp vs 2023 | PIF AUM: $941.3B ▲ +$345B vs 2022 | Inbound FDI: $21.3B ▼ -6.4% vs 2023 | Female Participation: 33% ▲ -1.1pp vs 2023 | Credit Rating: Aa3/A+ ▲ Moody's / Fitch | GDP Growth: 2.0% ▲ +1.5pp vs 2023 | Umrah Pilgrims: 16.92M ▲ vs 11.3M target |

Pharmaceuticals

Biotech and Life Sciences Investment

Guide to biotech and life sciences investment in Saudi Arabia covering pharma manufacturing, genomics, and medical devices.

Feb 22, 2026

Healthcare Private Investment

Guide to private healthcare investment in Saudi Arabia covering hospitals, clinics, medical devices, and digital health.

Feb 22, 2026

National Industry Strategy: Building Saudi Arabia's Manufacturing Base

An institutional analysis of Saudi Arabia's National Industry Strategy, examining the development of 36 industrial cities under MODON, manufacturing diversification into automotive, electronics, pharmaceuticals, and military industries, and the adoption of Fourth Industrial Revolution technologies.

Feb 22, 2026

Saudi Healthcare Companies

Overview of Saudi Arabia's private healthcare sector, covering leading hospital groups, pharmaceutical companies, medical technology firms, health insurance providers, and the growth drivers under the Health Sector Transformation Program.

Feb 22, 2026

Saudi Pharmaceutical Manufacturing

A detailed examination of Saudi Arabia's pharmaceutical manufacturing sector, covering localisation targets, key producers, regulatory developments, and the strategic alignment with Vision 2030's healthcare and [industrial diversification](/sectors/) objectives.

Feb 22, 2026

Saudi Pharmaceutical Manufacturing: Local Production Capacity and Health Security Strategy

Analysis of Saudi Arabia's pharmaceutical manufacturing covering local production, vaccine capacity, and health security.

Feb 22, 2026